TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026
A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults.
Catherine A Cosgrove et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.